Ninety One North America’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Ninety One North America’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-122,006	Closed	-$5.27M	–	123
2015 Q3	$5.27M	Buy	122,006 +23,511	+24%	+$992K	1.33%	42
2015 Q2	$4.16M	Buy	98,495 +2,482	+3%	+$105K	1.34%	36
2015 Q1	$3.72M	Sell	96,013 -37,359	-28%	-$1.44M	1.16%	36
2014 Q4	$4.49M	Buy	+133,372	New	+$4.71M	1.32%	27

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Ninety One North America's WX Position: Q4 2015 in Review

Ninety One North America sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 122,006 shares — an estimated $5.27M sold.

Ninety One North America first reported a position in WX in Q4 2014 and held it in 4 quarters. The position peaked at $5.27M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Ninety One North America reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Ninety One North America sold 122,006 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $5.27M.
Ninety One North America first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2014 and held it in 4 quarters.
Ninety One North America's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $5.27M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Ninety One North America's 13F filing for Q4 2015, filed 16 Feb 2016.